Two Recently Published Studies Support Use of DNA Testing on Biopsy Samples to Prevent Misdiagnoses
Washington University research demonstrates the incidence of biopsy sample misidentification, and cost-effectiveness of DNA provenance testing as part of the diagnostic testing cycle for cancer.
Read More